DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+12.57%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.11B
AUM Growth
+$4.11B
(+20%)
Cap. Flow
-$2.19M
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
37.55%
Holding
126
New
30
Increased
16
Reduced
24
Closed
24
Top Buys
| 1 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$129M |
| 2 |
Nkarta
NKTX
|
$72.7M |
| 3 |
CalciMedica
CALC
|
$67.1M |
| 4 |
Centene
CNC
|
$54.9M |
| 5 |
OSH
Oak Street Health, Inc.
OSH
|
$50.8M |
Top Sells
| 1 |
Schrodinger
SDGR
|
$123M |
| 2 |
Hologic
HOLX
|
$65.3M |
| 3 |
McKesson
MCK
|
$42.7M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$32.3M |
| 5 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$31.2M |
Sector Composition
| 1 | Healthcare | 62.18% |
| 2 | Financials | 1.23% |
| 3 | Industrials | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $197M | 4.79% | 13,274,000 +1,122,638 | +9% | +$16.6M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $196M | 4.77% | 2,304,900 -256,100 | -10% | -$21.8M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $142M | 3.47% | 1,832,767 -118,444 | -6% | -$9.2M |
|
|
AFIB
4
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $129M | 3.15% | +4,341,799 | New | +$129M |
|
|
DFPHU
5
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $114M | 2.78% | 10,460,000 | – | – |
|
|
6
Centene
CNC
$14.3B
| $107M | 2.6% | 1,828,000 +942,000 | +106% | +$54.9M |
|
|
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $96M | 2.34% | 704,000 | – | – |
|
8
Larimar Therapeutics
LRMR
$310M
| $78M | 1.9% | 5,144,539 | – | – |
|
|
9
Nkarta
NKTX
$151M
| $72.7M | 1.77% | +2,418,772 | New | +$72.7M |
|
10
Pacira BioSciences
PCRX
$1.2B
| $72M | 1.75% | 1,197,825 -465,175 | -28% | -$28M |
|
|
11
CalciMedica
CALC
$37.7M
| $67.1M | 1.63% | +5,281,713 | New | +$67.1M |
|
12
Mirum Pharmaceuticals
MIRM
$3.71B
| $66.5M | 1.62% | 3,448,912 | – | – |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $66.3M | 1.61% | 579,248 +393,248 | +211% | +$45M |
|
14
Revolution Medicines
RVMD
$7.1B
| $62.5M | 1.52% | 1,796,383 | – | – |
|
|
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
| $58.8M | 1.43% | 1,234,262 | – | – |
|
|
OSH
16
DELISTED
Oak Street Health, Inc.
OSH
| $50.8M | 1.24% | +951,063 | New | +$50.8M |
|
17
Annexon
ANNX
$226M
| $48.9M | 1.19% | +1,617,826 | New | +$48.9M |
|
|
XLRN
18
DELISTED
Acceleron Pharma Inc.
XLRN
| $47.4M | 1.16% | 421,619 | – | – |
|
19
Brookdale Senior Living
BKD
$1.83B
| $45M | 1.1% | 17,720,000 +3,809,101 | +27% | +$9.68M |
|
|
RETA
20
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $43.6M | 1.06% | 448,000 +186,235 | +71% | +$18.1M |
|
21
Rhythm Pharmaceuticals
RYTM
$6.85B
| $41.1M | 1% | 1,897,047 -572,966 | -23% | -$12.4M |
|
|
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
| $39.6M | 0.96% | 776,000 -632,603 | -45% | -$32.3M |
|
|
BPMC
23
DELISTED
Blueprint Medicines
BPMC
| $37.6M | 0.92% | 405,386 | – | – |
|
24
AdaptHealth
AHCO
$1.28B
| $37.3M | 0.91% | 1,710,674 +321,333 | +23% | +$7.01M |
|
25
Owens & Minor
OMI
$378M
| $37.1M | 0.9% | 1,477,000 | – | – |
|